Back to search
FDAFDA · Food and drugs·Recall number D-0326-2019

Valsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5814-77.

Published December 19, 2018 · Recall initiated: December 4, 2018

Summary

FDA records drug Class II recall D-0326-2019, published December 19, 2018 and initiated December 4, 2018. Recalling firm: Mylan Laboratories Limited, (Nashik FDF); Status: Ongoing; Reported quantity: 232,180 HDPE bottles; Lot: Lot Numbers: 3069019, 3069020, 3069021, 3069022, 3071354, 3071355, 3071357 3079023 3079027 3079028 3079029 3079996 3079997 3079998 3083635 3086715 3086716 3086717 3088623. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

What to do

Voluntary: Firm initiated · Press Release

Get an email if VALSARTAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VALSARTAN
Manufacturer
Mylan Laboratories Limited, (Nashik FDF)
Distributor
Product was distributed throughout the United States to several major distributors, including Puerto Rico.
UPC
0303785815778
Lot
Lot Numbers: 3069019, 3069020, 3069021, 3069022, 3071354, 3071355, 3071357 3079023 3079027 3079028 3079029 3079996 3079997 3079998 3083635 3086715 3086716 3086717 3088623
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Valsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5814-77. recalled?

Yes. FDA published recall D-0326-2019 on December 19, 2018. Reported hazard: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VALSARTAN. UPC: 0303785815778.